Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

NCT03793985 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: T
DRUG: R

Sponsor

Chong Kun Dang Pharmaceutical